Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
ISEMED and Arazy Group Sign Agreement for Advanced Regulatory Affair Technology
Global market access is now available to the Italian Medtech and IVD industry using advanced regulatory affair technology and management platforms. ISEMED (Imola, Italy) had signed a representation agreement with Arazy Group Consultant (Vancouver, BC, Canada) to become the Italian representative of Arazy's advanced regulatory affair technology, SaaS system and software specifically designed for medical and IVD device manufacturers. - November 08, 2022 - Arazy Group
Biomed Industries, Inc. (“Biomed”) Today Announced the Closing of Its Merger with MedAware Systems, Inc., (“MedAware”)
Biomed Industries, Inc. (“Biomed”) today announced the closing of its merger with MedAware Systems, Inc., (“MedAware”), in which all issued and outstanding common shares of capital stock of MedAware will be exchanged for common stock of Biomed at a ratio of 5.33 shares of MedAware for 1 new common share of Biomed. The transaction valued at an aggregate of $20 million, to be paid by 2,259,170 common shares of Biomed. At present, Biomed has approximately 76,354,075 common shares issued. - November 07, 2022 - Biomed Industries, Inc.
New Pivotal Data Demonstrates Clinical Feasibility of GeneFluidics’ Direct-from-Specimen AST in Clinical Settings
GeneFluidics, Inc. is pleased to announce a joint publication with the Medical College of Wisconsin (MCW) that introduces rapid antimicrobial susceptibility testing (AST), which would represent a paradigm shift in the clinical management of microbial infections. The data from the MCW study have... - November 04, 2022 - GeneFluidics Inc.
Securisyn Medical seeks up to $5 Million Crowd SAFE Raise for Commercialization of its Clinically Differentiated Ventilated Patient Safety Technology Platform
Securisyn Medical, LLC (“Securisyn Medical” or the “Company”) is a commercial-stage medical technology company and the developer of the patented SolidAIRity Flex® Oral Endotracheal Tube Stabilizer System, announced today the launch of its $5 Million Crowd SAFE... - November 02, 2022 - Securisyn Medical
CancerLife Announces a New Platform to Address Disparities of Care with Breast Cancer
CancerLife announces the results of a clinical trial where QoL was raised by 14.3% across all care settings, which proves it solution can address disparities of care. - October 29, 2022 - CancerLife
Gallant Announces Hiring of John Klacking, Ph.D. as Chief Business Officer
Furthering its regenerative medicine therapeutics research and development, animal biotech company Gallant welcomes a pioneer in the biotech space. - October 25, 2022 - Gallant
UTECH® Products Expands Operations to Abu Dhabi, Totaling Eight International Offices
UTECH® Products Inc., a medical and laboratory equipment and supplies company is pleased to announce expanding operations to Abu Dhabi, United Arab Emirates, making it its 8th office worldwide. UTECH is bringing its expansive offerings to the Middle East market as a global leader in medical... - October 25, 2022 - EndoSoft
Creative Diagnostics Launches Monkeypox Virus Antigens and Antibodies to Accelerate MPXV Study
Creative Diagnostics announced the launch of Monkeypox Virus Antigens and Antibodies to support scientists focused on the research of monkeypox virus. - October 23, 2022 - Creative Diagnostics
CloudLIMS Exhibits Its Truly Configurable, No Upfront Cost LIMS @Lab Innovations 2022
CloudLIMS showcases its zero upfront cost, cloud-based Laboratory Information Management System (LIMS) @Lab Innovations at booth G6 from November 2-3, 2022. - October 20, 2022 - CloudLIMS
Kantify and Mcule Harness the Power of Data to Accelerate Drug Discovery
Kantify, using its AI technology for drug discovery and Mcule, with its compound sourcing platform, are collaborating to leverage data for better hit prediction. - October 17, 2022 - Mcule
Biolexis Therapeutics Announces Launch of FIELDS, an AI/ML Drug Discovery Platform
Biolexis is the first company to combine a curated historical wet-lab database, including half-a-million targets of binding data points, with an automated AI/ML-augmented discovery platform. - October 14, 2022 - Biolexis Therapeutics Inc.
High-Standard Fermented Raw Materials That Satisfy the Quality Attributes of Healthcare Products
BOC Sciences is able to provide clients with high-standard fermented raw materials that satisfy the quality attributes of finished healthcare products. - October 13, 2022 - BOC Sciences
Mirror Biologics, Inc. Announces Additional $20 Million Investment to Close Out $30 Million Series A Investment Round
Mirror Biologics, Inc., a clinical stage biopharmaceutical company today announced the completion of the final $20 million tranche of its $30 million Series A investment round with Bradbury Asset Management (Hong Kong), Limited. Bradbury provided an initial $10 million tranche for this round in... - October 11, 2022 - Mirror Biologics, Inc.
Tasly Pharmaceuticals to Exhibit at BioJapan 2022 -- Bio-Pharmaceutical Company to Join with Maryland-Based Organizations at Asia’s Premier Biotechnology Partnering Event
Tasly Pharmaceuticals will exhibit at BioJapan 2022, October 12-14 at PACIFICO Yokohama - October 05, 2022 - Tasly Pharmaceuticals, Inc.
ALS Therapy Development Institute Announces Superior Rail & Iron Works, Inc. as First Title Sponsor of White Coat Affair Gala
Superior Rail & Iron Works, Inc. will be the first Title Sponsor of the White Coat Affair gala, being held on October 15, 2022, at the Boston Sheraton to raise funds for ALS research. - September 28, 2022 - ALS Therapy Development Institute
Creative Diagnostics Introduces Highly Sensitive Cytopathic Effect Inhibition Assay Service
Creative Diagnostics introduced the Cytopathic Effect Inhibition Assay Service of high assay sensitivity and accuracy. - September 28, 2022 - Creative Diagnostics
In 4 Weeks Meet Pfizer, AstraZeneca, DiME & Many More at the Biosensors for Medical Wearables Conference
SAE Media Group reports: The Biosensors for Medical Wearables Conference will welcome Pfizer, AstraZeneca, DiMe, MedRhythms and many more biotech companies. - September 26, 2022 - SAE Media Group
New Decentralized Clinical Trial (DCT) Patient Satisfaction and Participation Report
800 Current and Future Clinical Trial Participants Link Satisfaction and Willingness to Participate with Decentralized Strategies - September 21, 2022 - Life Science Strategy Group, LLC
Serpin Pharma Awarded Competitive NCI Grant for SP16
The National Cancer Institute awarded Serpin Pharma a $400,000 competitive R43 grant for the Pre-clinical validation of phase II peptide LRP-1 agonist to treat and prevent chemotherapy-induced peripheral neuropathy. The Principal Investigators are Serpin Pharma's CEO and Executive Chairperson, Dr. - September 20, 2022 - Serpin Pharma, LLC
Key Topics Not to Miss at the Wearable Injectors and Connected Devices Conference
SAE Media Group: key topics and presentations released for ahead of the Wearable Injectors and Connected Devices Conference. - September 01, 2022 - SAE Media Group
Creative Diagnostics Launches New Livestock Infectious Diseases Antigens
Creative Diagnostics announced the launch of more than 20 antigens for the development of veterinary infectious diseases diagnostics and vaccines. - August 26, 2022 - Creative Diagnostics
NanoCellect Biomedical Awarded $1.8M Federal Grant to Advance Imaging Flow Cytometry with Artificial Intelligence Technologies
NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced it has received a $1.8 million Phase II Small Business Innovation Research (SBIR) grant through the National Institutes of Health’s National... - August 24, 2022 - NanoCellect Biomedical
Key Presentations at the Medical Devices & IVD Conference Released
SAE Media Group reports: ahead of the conference in November, key presentations are released for the Medical Devices & IVD Conference. - August 18, 2022 - SAE Media Group
Respiratory Monitoring & AI Technologies – Hear More at the Biosensors for Medical Wearables Conference
SAE Media Group reports: the Biosensors for Medical Wearables Conference will cover AI technologies and respiratory monitoring. - August 17, 2022 - SAE Media Group
VMRD Begins Manufacturing Key Reagent for Detection of CWD by RT-QuIC
Veterinary Medical Research & Development (VMRD), Pullman, WA, has partnered with CWD Evolution, Fort Collins, CO, to provide state-of-the-art diagnostic reagents for detection of the abnormal prion associated with Chronic Wasting Disease (CWD). The control of CWD requires identification of... - August 09, 2022 - VMRD, Inc.
Hemanext Announces Publication of Hypoxic Blood Storage Study in Blood Advances
Research shows that hypoxic storage preserves faster oxygen unloading from red blood cells compared to standard conditions. - August 05, 2022 - Hemanext
Stable and Quality Supply of Phosphoramidites is a Reality at BOC Sciences
As an expert in chemistry, BOC Sciences understands how important the quality of phosphoramidite is to successful oligo synthesis and remarkably, it has taken concrete actions to manufacture certified products. - August 05, 2022 - BOC Sciences
BOC Sciences Shares Its Strategic Emphasis on NTPs During the Pandemic
"Whether your studies involve DNA sequencing, cDNA synthesis, RT-PCR, RCA, MDA, DNA labeling, in vitro transcription, siRNA synthesis, or RNA amplification, we stock hundreds of modified or natural NTPs to suit your various molecular biological applications," a BOC Sciences manager announces to the public. - August 05, 2022 - BOC Sciences
Creative Diagnostics Introduces New Cell-Based ELISA Services
Creative Diagnostics is offering comprehensive services for Cell-based ELISA that can measure the reduction of viral antigens in infected cells using anti-virus antibodies or compounds. - July 22, 2022 - Creative Diagnostics
Julia Harwood Promoted to Senior Vice President of Clinical Operations for New York Cancer & Blood Specialists
New York Cancer & Blood Specialists (NYCBS) announced today the appointment of Julia Harwood to Senior Vice President of Clinical Operations. https://nycancer.com/news/julia-harwood-promoted-to-senior-vice-president-of-clinical-operations-for-new-york-cancer-and-blood-specialists Harwood... - July 20, 2022 - New York Cancer & Blood Specialists
Mako Medical CEO Chad Price Announces Company Expansion in Virginia with the Alliance
Chad Price, CEO of Raleigh-based Mako Medical and Mako Medical Laboratories, announced the company is expanding its service throughout the state of Virginia by adding a new member to the laboratory Alliance. - July 18, 2022 - Mako Medical Laboratories
Chad Price, CEO of Raleigh-Based Mako Medical & Mako Medical Laboratories Launches a New Monkeypox Test
Chad Price, CEO of Mako Medical, recently announced his team has developed a monkeypox test. - July 18, 2022 - Mako Medical Laboratories
Michael Cerminaro to Succeed Marvin Woodall as CEO of Thrombolex Woodall to Remain Executive Chairman of the Board of Directors
Thrombolex today announced that its Board of Directors has named Michael Cerminaro Chief Executive Officer (CEO) of Thrombolex effective July 13, 2022, the date of the Company’s most recent Quarterly Board Meeting. Mr. Cerminaro will also retain his current title of President. Mr. Woodall,... - July 18, 2022 - Thrombolex, Inc.
Brochure Available for Biosensors for Medical Wearables Conference 2022
SAE Media Group reports: the full agenda and speaker line-up is now available for 2nd Annual Biosensors for Medical Wearables conference. - July 13, 2022 - SAE Media Group
PharmStars Announces Spring 2022 Accelerator Graduates: 11 Digital Health Startups Have Successfully Completed PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Spring 2022 program. The graduates successfully completed the 10-week PharmaU program, which culminated with the Showcase Event held June 8-10 in Boston. The Showcase Event brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - July 12, 2022 - PharmStars
Immundiagnostik and Preventis GmbH Go Beyond the Lab at the AACC’s Annual Scientific Meeting and Clinical Lab Expo
Immundiagnostik and Preventis GmbH will exhibit together at the upcoming AACC Clinical Lab Expo July 26-28 in Chicago, IL in support of improved patient care. - July 11, 2022 - Immundiagnostik, Inc.
ReproTech, LLC Welcomes New President & CEO, William Braun
ReproTech, LLC, the industry leader in human reproductive tissue cryogenic storage, is pleased to announce that William J. Braun has been selected as ReproTech’s new President and Chief Executive Officer. Braun assumed the role on April 4, 2022, and will be based in ReproTech’s Coconut Creek, FL location. - July 09, 2022 - ReproTech, LLC
Global Cancer Technology Successfully Concludes Glioblastoma Pre-Clinical Animal Studies with Impressive Results
Global Cancer Technology, a San Diego, CA biotechnology company, has successfully completed animal testing with GCT.GLIO.1, a PI3K selective inhibitor that can cross the blood brain barrier and modulate immune cell function. The company will advance the compound to Phase 1 clinical trials as a next step. - July 08, 2022 - Global Cancer Technology
Network with Johnson & Johnson, Springboard, BSI, AstraZeneca and Many More at the Wearable Injectors & Connected Devices Conference
SAE Media Group reports: The full agenda and speaker line-up are now available to download for the 3rd Annual Wearable Injectors and Connected Devices Conference, returning in October 2022. - July 08, 2022 - SAE Media Group
Terrain Health Partners with Novel Biotech Company Microgenesis to Offer Breakthrough Solutions for Infertility
Terrain Health, an international precision healthcare organization partners with novel biotechnology, science research company Microgenesis, to offer a natural and effective solution to restore fertility potential by identifying root cause of infertility issues, now shown to be linked to the health of the gut microbiome. - July 06, 2022 - Terrain Health Inc.
Hemanext Announces Appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East, and Africa
Hemanext Inc. (“Hemanext” or the “Company”), a leading innovator in blood processing and storage technology, today announced the appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East and Africa (EMEA). In his role,... - July 05, 2022 - Hemanext
Bench International Launches "Digitization of Healthcare Technology" Practice
Practice Supported by Visionaries in Digital Technology to Complement Bench’s 45+ Years in Life Sciences Executive Search - June 23, 2022 - Bench International
New Integrated Controls Streamline Essential Force Measurement
Mark-10 introduces the Series F family of force testers for quality control and process monitoring in manufacturing, research, and engineering applications. Suitable for diverse uses in the medical device, packaging, automotive, aerospace, and other industries, the Series F family integrates... - June 21, 2022 - Mark-10 Corporation
PharmStars Announces “Innovations in Real-World Evidence” Theme for Fall 2022 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, announces it is now accepting applications for its Fall 2022 cohort with the theme, “Innovations in Real-World Evidence.” - June 15, 2022 - PharmStars
Defined Bioscience Announces Formation of Scientific Advisory Board
Defined Bioscience, a life science tools company pioneering the development of next generation ingredients for cell culture, today announced the formation of its scientific advisory board (SAB). The SAB is comprised of a distinguished group of academic and industry experts who will advise the... - June 15, 2022 - Defined Bioscience Inc.
Creative Diagnostics Introduces CC50/IC50 Assay Services for Pharmaceutical Safety
Creative Diagnostics introduced CC50/IC50 testing services with a high level of detection sensitivity and accuracy. - June 11, 2022 - Creative Diagnostics
PharmStars Announces Showcase Pitch Event for Spring 2022 Cohort
PharmStars, the pharma-focused accelerator for digital health startups, announces the start of its Showcase Event on June 8, 2022. The digital health startups that participated in the 10-week accelerator program will make formal presentations to, and answer questions from, the pharma members of PharmStars. All of PharmStars’ seven members are participating in the Showcase Event. - June 08, 2022 - PharmStars
Creative Diagnostics Announces Antigens for Epstein-Barr Virus Antibody Tests
Creative Diagnostics recently launched recombinant antigens p18 and p23 (viral capsid antigens, VCA), p54 and p138 (early antigens, EA) and EBNA1 (nuclear antigen, EBNA). - May 26, 2022 - Creative Diagnostics
Molekule Consulting Announces the Launch of E.U. - Based Operations
Molekule Consulting announces the launch of an E.U. - based business / Molekule Hub continuing their focus on the development of global strategy and advisory services for the biopharmaceutical sector. - May 24, 2022 - Molekule Consulting
Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology
Global Cancer Technology is developing innovative treatments for deadly diseases like cancer, with a current focus on glioblastoma and breast cancer. To date, Mr. Robert Proulx has held numerous Board positions, is a recognized thought leader in biopharma, and currently holds dual roles as the founder and CEO of Imagion Biosystems. - May 21, 2022 - Global Cancer Technology